000 | 01537 a2200493 4500 | ||
---|---|---|---|
005 | 20250513134619.0 | ||
264 | 0 | _c19980219 | |
008 | 199802s 0 0 eng d | ||
022 | _a0098-7484 | ||
024 | 7 |
_a10.1001/jama.279.6.435 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenstein, N | |
245 | 0 | 0 |
_aEfficacy of meningococcal vaccine and barriers to vaccination. _h[electronic resource] |
260 |
_bJAMA _cFeb 1998 |
||
300 |
_a435-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBacterial Vaccines _xadministration & dosage |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDisease Outbreaks _xprevention & control |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMeningococcal Infections _xprevention & control |
650 | 0 | 4 | _aMeningococcal Vaccines |
650 | 0 | 4 |
_aNeisseria meningitidis _xclassification |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSerotyping |
650 | 0 | 4 |
_aTexas _xepidemiology |
650 | 0 | 4 |
_aUnited States _xepidemiology |
650 | 0 | 4 |
_aVaccination _xstatistics & numerical data |
700 | 1 | _aLevine, O | |
700 | 1 | _aTaylor, J P | |
700 | 1 | _aEvans, D | |
700 | 1 | _aPlikaytis, B D | |
700 | 1 | _aWenger, J D | |
700 | 1 | _aPerkins, B A | |
773 | 0 |
_tJAMA _gvol. 279 _gno. 6 _gp. 435-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.279.6.435 _zAvailable from publisher's website |
999 |
_c9435592 _d9435592 |